Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.15 EUR | -.--% | +1.32% | -30.51% |
May. 27 | Ulisse Biomed, agreement with Elettrobiochimica for IVDR kit development | AN |
May. 20 | Ulisse Biomed S.p.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2024 * | 2.2M 2.38M | Sales 2025 * | 3.35M 3.63M | Capitalization | 25.08M 27.19M |
---|---|---|---|---|---|
Net income 2024 * | -2M -2.17M | Net income 2025 * | -2M -2.17M | EV / Sales 2024 * | 10.8 x |
Net cash position 2024 * | 1.27M 1.38M | Net cash position 2025 * | 1.19M 1.29M | EV / Sales 2025 * | 7.13 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 9 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 92.9% |
1 week | +1.32% | ||
1 month | -6.50% | ||
3 months | -25.08% | ||
6 months | -31.75% | ||
Current year | -30.51% |
Managers | Title | Age | Since |
---|---|---|---|
Bruna Marini
FOU | Founder | 39 | - |
Rudy Ippodrino
FOU | Founder | - | - |
Matteo Petti
CEO | Chief Executive Officer | 41 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Luigi Colombo
BRD | Director/Board Member | 61 | - |
Matteo Petti
CEO | Chief Executive Officer | 41 | - |
Laura Amadesi
BRD | Director/Board Member | 56 | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 1.15 | -.--% | 8,000 |
24-05-30 | 1.15 | +0.88% | 15,000 |
24-05-29 | 1.14 | -2.56% | 17,000 |
24-05-28 | 1.17 | +0.43% | 19,000 |
24-05-27 | 1.165 | +2.64% | 5,000 |
Real-time Borsa Italiana, May 31, 2024 at 11:44 am EDT
More quotesChiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-30.51% | 27.19M | |
+43.36% | 54.63B | |
-5.31% | 39.92B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B | |
-11.83% | 10.74B |
- Stock Market
- Equities
- UBM Stock